Medical Monitoring Project

The summary for the Medical Monitoring Project grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.

Medical Monitoring Project: MMP is an ongoing, locally and nationally representative surveillance system that collects data on a probability sample of HIV-diagnosed adults in the United States. MMP monitors sociodemographic variables, behavioral and clinical characteristics, supportive service needs, use of healthcare and prevention services, and adherence to clinical care guidelines among HIV-diagnosed adults. The data from MMP and associated projects are used to help inform and guide local and national HIV prevention, care, and treatment efforts.

Federal Grant Title:	Medical Monitoring Project
Federal Agency Name:	Centers for Disease Control and Prevention
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	CDC-RFA-PS15-1503
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.944
CFDA Descriptions:	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance
Current Application Deadline:	Jan 8, 2015 Dates: Letter of Intent (LOI) Dead
Original Application Deadline:	Jan 8, 2015 Dates: Letter of Intent (LOI) Dead
Posted Date:	September 8th, 2014
Creation Date:	Sep 8, 2014
Archive Date:	Feb 7, 2015
Total Program Funding:	$96,000,000
Maximum Federal Grant Award:	$1,800,000
Minimum Federal Grant Award:	$300,000
Expected Number of Awards:	26
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: A. Eligibility Information
1. Eligible Applicants:
Government Organizations:
• State or their bona fide agents (includes the District of Columbia)
• Local governments or their bona fide agents
• Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau)
2. Special Eligibility Requirements: N/A
3. Justification for Less than Maximum Competition:
The Medical Monitoring Project or MMP is a national public health surveillance program designed to collect clinical and behavioral information on those diagnosed with HIV or AIDS. Competition for MMP funds is limited to the twenty-six (26) established MMP sites originally selected in 2004. These particular sites were selected to represent the HIV epidemic in the United States. Process for the selection and establishment of MMP sites has been published in a scientific journal; a detailed description of the process used for selection is available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462615/pdf/TOAIDJ-6-67.pdf.
The established MMP sites have enabled CDC to obtain data that represent the country as a whole starting in 2004. Ascertainment of representative national data is the goal of MMP.

Twenty States or territories, including six jurisdictions which are separately funded for other HIV/AIDS program activities within states, were selected to participate in MMP in 2004. These 26 sites have built the capacity to successfully perform MMP and enable CDC to meet surveillance goals by producing national estimates characterizing the US epidemic. The selected sites were: California Department of Health Services; Chicago Department of Public Health; Delaware Department of Health and Social Services; Florida Department of Health; Georgia Department of Public Health; Houston Department of Health and Human Services; Illinois Department of Public Health; Indiana State Department of Health; Los Angeles County Health Department; Maryland Department of Health and Mental Hygiene; Massachusetts Department of Public Health; Michigan Department of Community Health; Mississippi Department of Health; New Jersey Department of Health and Senior Services; New York City Department of Health and Mental Hygiene; New York State Department of Health; North Carolina Department of Health and Human Services; Oregon Department of Human Services; Pennsylvania Department of Health; Philadelphia Department of Public Health; Puerto Rico Health Department; San Francisco Department of Public Health; South Carolina Department of Health and Environmental Control; Texas Department of State Health Services; Virginia Department of Health; and Washington State Department of Health. These are the twenty-six areas eligible to apply and continue to conduct MMP activities.

In order to appropriately use MMP data for prevention and to evaluate national HIV-related health care initiatives including portions of the Affordable Care Act, the data collected in MMP must be nationally representative. If competition is not limited to the 26 established sites listed above, MMP would not be adhering to the scientific sampling strategy chosen for its project design. Without this adherence, MMP data would not be nationally representative and would no longer produce reports that represent the HIV epidemic in the United States.
Grant Announcement Contact: CDC Procurement and Grants Office (PGO) Technical Information Management Section (TIMS) Phone: 770-488-2700 E-mail: [email protected]
Technical Information Management Section (TIMS)

Centers for Disease Control and Prevention 770-488-2756
Similar Government Grants: • Enhanced surveillance of persons with early and late HIV diagnosis to understand system an...; • Transgender Status-Neutral Community-to-Clinic Models to End the HIV Epidemic; • National HIV Behavioral Surveillance (NHBS); • Medical Monitoring Project (MMP); • Augmenting Laboratory Outcomes in HIV Assessment (ALOHA); • ADAPT: Adopting and Demonstrating the Adaption of Prevention Techniques - Supplement; • Morbidity and Risk Behavior Surveillance
More Grants from the Centers for Disease Control and Prevention: • Advancing Diagnostic Network Optimization, Stepwise Laboratory Accreditation, and Integrat...; • Strengthening Public Health Systems and Services through National Partnerships to Improve ...; • 93.067; • Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities o...; • Technical Assistance to Support Comprehensive Combination HIV Prevention, Care and Treatme...